Puma Biotechnology Inc (PBYI)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Puma Biotechnology Inc-Aktie (PBYI)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	38.51% 75.45	54.48	52.44	46.01	80.54
Cost Of Revenue	89.99% 23.13	12.17	12.30	10.56	29.10
Gross Profit	23.70% 52.33	42.30	40.13	35.45	51.45
Operating Expenses	7.61% 35.22	32.73	33.50	31.47	29.37
Benefits Costs and Expenses	28.99% 58.35	45.23	46.27	42.74	59.93
Costs And Expenses	29.94% 58.35	44.90	45.80	42.02	58.46
Depreciation and Amortization	2.39% 2.657	2.722	2.763	2.796	2.878
Operating Income/Loss	78.69% 17.11	9.573	6.636	3.984	22.08
Nonoperating Income/Loss	100.30% 0.001	-0.33	-0.471	-0.717	-1.471
Income/Loss From Continuing Operations Before Tax	85.08% 17.11	9.243	6.165	3.267	20.61
Income Tax Expense/Benefit, Current	6.27% 0.424	0.399	0.31	0.293	-
Income Tax Expense/Benefit	819.55% 3.669	0.399	0.31	0.293	0.291
Income/Loss From Continuing Operations After Tax	51.94% 13.44	8.844	5.855	2.974	20.32
Net Income/Loss	51.94% 13.44	8.844	5.855	2.974	20.32
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.74% 0.1303	50.34	49.70	49.60	49.01
Diluted Average Shares	99.37% 0.3187	50.93	50.14	49.91	49.17
Basic Earnings Per Share	50.00% 0.27	0.18	0.12	0.06	0.41
Diluted Earnings Per Share	52.94% 0.26	0.17	0.12	0.06	0.41
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%